National Coverage Analysis (NCA) View Public Comments

Positron Emission Tomography (NaF-18) to Identify Bone Metastasis of Cancer

Public Comments

Commenter Comment Information
Li, Yi Title: Radiologist
Organization: Good Samaritan Hospital
Date: 10/16/2015
Comment:
NaF-18 PET imaging is a very good tool which will significantly improve the outcome of diagnosis. We should have it for daily medical practice.
Ambrosy, Dolores Title: Imaging Manager and Chief Technologist
Date: 10/16/2015
Comment:
In my twenty years as a Nuclear Medicine Technologist it has become clear to me that Sodium Flouride Bone scans are FAR SUPERIOR to planar bone scans. MDP bone scan usually lead to further imaging because of inconclusive findings which create an inconvenience for the patient. This creates a situation where a patient needs further testing!! I have also witnessed situations where planar bone scan might be read as having slightly increased areas of uptake which may not look like metastasis

More

Bonvicino, Marie Title: MD
Organization: Life Line Medical
Date: 10/16/2015
Comment:

F-18 Sodium fluoride PET bone scanning is far superior to the regular bone scans in our area.

Here are some cases:

1.) A 65 year old with lung cancer, FDG scan shows disease above right hip, and disease in front of left hip. For some reason one of our physicians orders a regular bone scan which is read as “”negative””.. “”There is no scintigraphic evidence of bony metastases, despite suspicious findings on the recent [FDG} PET scan”“; “”Normal bone scan”“ (SIC). This

More

Hertel, Donald Title: Manager, Medicare Starategy Unit
Organization: Mayo Clinic
Date: 10/16/2015
Comment:

Commenter: Roarke, Michael
Title: Consultant Diagnostic Radiology
Organization: Mayo Clinic
Date: 10/13/2015
Comment:

Tamara Syrek Jensen, JD
Director, Coverage and Analysis Group
Centers for Medicare and Medicaid Services

Dear Ms. Syrek Jensen:

On behalf of Mayo Clinic we appreciate the opportunity to submit public comments to the Centers for Medicare & Medicaid Services (CMS) Proposed Decision Memo for Positron Emission Tomography (NaF-18)

More

Djang, David Title: MD
Organization: Swedish Cancer Institute, Seattle WA
Date: 10/16/2015
Comment:

In our experience, the NaF-18 studies have been both more sensitive and more specific for detecting bone metastases than traditional Tc-99m MDP bone scans. Not only does this lead to more accurate diagnoses, it also requires fewer confirmation studies, often MRIs, to investigate the non-specific findings that are more often reported with the Tc99m MDP bone scans.

These NaF-18 studies demonstrate significant clinic impact. More accurate, more confident results have resulted in a

More

Flynn, Thomas Title: Chairman, National Policy Board
Organization: The US Oncology Network
Date: 10/16/2015
Comment:

October 16, 2015

Tamara Syrek Jensen, J.D.
Director, Coverage and Analysis Group
Office of Clinical Standards and Quality
Centers for Medicare & Medicaid Services
7500 Security Boulevard,
Baltimore, MD 21244-1850

Via Online Submission

RE: Comments on the Proposed Decision Memo for Positron Emission Tomography (NaF-18) to Identify Bone Metastasis of Cancer (CAG-00065R2)

Dear Director Syrek Jensen:

On behalf of the National Policy

More

Kennedy, Stephen Title: MD
Organization: St Anthony's Hospital
Date: 10/16/2015
Comment:
I have found NaF-18 to be very helpful in my practice. I am able to identify metastatic disease to the bone with greater certainty than traditional bone scintigraphy.
Bunning, Susan Title: Director, Health Policy and Regulatory Affairs
Organization: Society of Nuclear Medicine and Molecular Imaging
Date: 10/16/2015
Comment:

October 16, 2015

Tamara Syrek Jensen, Esq.
Director, Coverage and Analysis Group
Centers for Medicare & Medicaid Services
7500 Security Blvd
Baltimore, MD 21244

RE: Comments on Positron Emission Tomography (NaF-18) To Identify Bone Metastasis of Cancer (CAG-00065R) Proposed Decision Memorandum

Dear Director Syrek Jensen:

The Society of Nuclear Medicine and Molecular Imaging (SNMMI), the American College of Nuclear Medicine (ACNM)

More

Wilf, Larry Title: Nuclear radiologist
Organization: 21st century oncology
Date: 10/16/2015
Comment:
Our group is a multispecialty oncology group which performs a substantial amount of PET/CT imaging. I am a tenured Associate Professor of Radiology at the University of Florida.
Having performed gamma camera bone scan for over 20 years ..and now NaF18 BS since 2004, I can tell you without hesitation , there is no comparison. In my mind, performing a gamma camera BS in this day and age is malpractice. The PET scan sensitivity and resolution are beyond comparison and the added information (

More

Doss, Mohan Title: Associate Professor
Organization: Fox Chase Cancer Center, Philadelphia, PA 19111
Date: 10/16/2015
Comment:
Dear Colleagues,
I have read the publications that have summarized results from 18F-NaF PET scans. There is indeed considerable evidence for the utility of these PET scans, as indicated by the change in treatment plan following the scans in a large fraction of the patients. I would urge you to reconsider your conclusion that there is not sufficient evidence for the use of NaF-18 PET scans to identify bone metastasis of cancer. Thank you for your

More

Singh, Amolak Title: Professor, Chief and Chairman
Organization: Nuclear Medicine, University of MO-Columbia
Date: 10/16/2015
Comment:
Bone scans with F-18 NAF are so much better that it will replace Tc-99 m Bone scans which are insensitive and often miss cancer and as well benign pathology. It is disservice to patients to use inferior method of bone scanning when far better method for bone scanning is available. Please approve this ASAP.
Krynyckyi, Borys Title: MD
Organization: PCMI
Date: 10/16/2015
Comment:

We have been using NAF PET bone scans since 2008, they have been remarkably useful, especially when compared to simple suboptimal planar bone scans.

The combination of superior 3-D resolution on the emission portion, coupled to the simultaneously acquired CT, has provided clinicians much useful data.

In our community conventional planar bone scans with MDP are only 50% accurate!!

Using NAF PET scans, we are able to routinely identify arthritis/degenerative

More

Wilson, Terri Title: Director, Molecular Imaging & PET
Organization: Medical Imaging & Technology Alliance
Date: 10/16/2015
Comment:

Tamara Syrek Jensen, Esq.
Director, Coverage and Analysis Group
Centers for Medicare & Medicaid Services
Department of Health and Human Services
7500 Security Boulevard
Baltimore, MD 21244

Re: Comments on Proposed Decision Memorandum (CAG-00065R2)
Positron Emission Tomography (NaF-18) to Identify Bone Metastasis of Cancer

Dear Director Syrek Jensen:

The Medical Imaging & Technology Alliance (MITA) appreciates this opportunity to submit

More

Contag, PhD, Christopher H. Title: President
Organization: World Molecular Imaging Society
Date: 10/15/2015
Comment:

Dear Director Syrek Jensen:

The World Molecular Imaging Society (WMIS) appreciates the opportunity to comment on the Proposed Decision Memorandum on Positron Emission Tomography (NaF-18) (CAG-00065R). We were disappointed to learn that the Centers for Medicare & Medicaid Services (CMS) proposes to find that the data is insufficient to determine that NaF PET is reasonable and necessary for the identification of bone metastatis of cancer, and further proposes to continue Coverage

More

Yoskin, Maruice Title: Dr.
Organization: Lake Medical Imaging
Date: 10/15/2015
Comment:
Lake Medical Imaging radiologists disagree with the proposed decision and feel strongly that 18F NaF should be nationally covered by CMS because of its value in patient management.
Weyn, David Title: Dr.
Organization: Lake Medical Imaging
Date: 10/15/2015
Comment:
Lake Medical Imaging radiologists disagree with the proposed decision and feel strongly that 18F NaF should be nationally covered by CMS because of its value in patient management.
Serafain, Anton Title: Dr.
Organization: Lake Medical Imaging
Date: 10/15/2015
Comment:
Lake Medical Imaging radiologists disagree with the proposed decision and feel strongly that 18F NaF should be nationally covered by CMS because of its value in patient management.
Schwartzberg, Marc Title: Dr.
Organization: Lake Medical Imaging
Date: 10/15/2015
Comment:
Lake Medical Imaging radiologists disagree with the proposed decision and feel strongly that 18F NaF should be nationally covered by CMS because of its value in patient management.
Paymani, Mahrad Title: Dr.
Organization: Lake Medical Imaging
Date: 10/15/2015
Comment:
Lake Medical Imaging radiologists disagree with the proposed decision and feel strongly that 18F NaF should be nationally covered by CMS because of its value in patient management.
Patel, Romil Title: Dr.
Organization: Lake Medical Imaging
Date: 10/15/2015
Comment:
Lake Medical Imaging radiologists disagree with the proposed decision and feel strongly that 18F NaF should be nationally covered by CMS because of its value in patient management.
McMullen, Laird Title: Dr.
Organization: Lake Medical Imaging
Date: 10/15/2015
Comment:
Lake Medical Imaging radiologists disagree with the proposed decision and feel strongly that 18F NaF should be nationally covered by CMS because of its value in patient management.
Liu, Yi Title: Dr.
Organization: Lake Medical Imaging
Date: 10/15/2015
Comment:
Lake Medical Imaging radiologists disagree with the proposed decision and feel strongly that 18F NaF should be nationally covered by CMS because of its value in patient management.
Levine, Michael Title: Dr.
Organization: Lake Medical Imaging
Date: 10/15/2015
Comment:
Lake Medical Imaging radiologists disagree with the proposed decision and feel strongly that 18F NaF should be nationally covered by CMS because of its value in patient management.
Keller, Cathrine Title: Dr.
Organization: Lake Medical Imaging
Date: 10/15/2015
Comment:
Lake Medical Imaging radiologists disagree with the proposed decision and feel strongly that 18F NaF should be nationally covered by CMS because of its value in patient management.
Kainz, George Title: Dr.
Organization: Lake Medical Imaging
Date: 10/15/2015
Comment:
Lake Medical Imaging radiologists disagree with the proposed decision and feel strongly that 18F NaF should be nationally covered by CMS because of its value in patient management.
Houston, Steve Title: Dr.
Organization: Lake Medical Imaging
Date: 10/15/2015
Comment:
Lake Medical Imaging radiologists disagree with the proposed decision and feel strongly that 18F NaF should be nationally covered by CMS because of its value in patient management.
Hira, Ajay Title: Dr.
Organization: Lake Medical Imaging
Date: 10/15/2015
Comment:
Lake Medical Imaging radiologists disagree with the proposed decision and feel strongly that 18F NaF should be nationally covered by CMS because of its value in patient management.
Held, Richard Title: Dr.
Organization: Lake Medical Imaging
Date: 10/15/2015
Comment:
Lake Medical Imaging radiologists disagree with the proposed decision and feel strongly that 18F NaF should be nationally covered by CMS because of its value in patient management.
Hameedi, Amir Title: Dr.
Organization: Lake Medical Imaging
Date: 10/15/2015
Comment:
Lake Medical Imaging radiologists disagree with the proposed decision and feel strongly that 18F NaF should be nationally covered by CMS because of its value in patient management.
Gurinsky, Joseph Title: Dr.
Organization: Lake Medical Imaging
Date: 10/15/2015
Comment:
Lake Medical Imaging radiologists disagree with the proposed decision and feel strongly that 18F NaF should be nationally covered by CMS because of its value in patient management.
Diaz, Rosendo Title: Dr.
Organization: Lake Medical Imaging
Date: 10/15/2015
Comment:
Lake Medical Imaging radiologists disagree with the proposed decision and feel strongly that 18F NaF should be nationally covered by CMS because of its value in patient management.
Chang, Pairoj Title: Dr
Organization: Lake Medical Imaging
Date: 10/15/2015
Comment:
Lake Medical Imaging radiologists disagree with the proposed decision and feel strongly that 18F NaF should be nationally covered by CMS because of its value in patient management.
Carroll, J. Scott Title: Dr.
Organization: Lake Medical Imaging
Date: 10/15/2015
Comment:
Lake Medical Imaging radiologists disagree with the proposed decision and feel strongly that 18F NaF should be nationally covered by CMS because of its value in patient management.
Bhatia, Manoj Title: Dr.
Organization: Lake Medical Imaging
Date: 10/15/2015
Comment:
Lake Medical Imaging radiologists disagree with the proposed decision and feel strongly that 18F NaF should be nationally covered by CMS because of its value in patient management.
Bajayo, David Title: Dr.
Organization: Lake Medical Imaging
Date: 10/15/2015
Comment:
Lake Medical Imaging radiologists disagree with the proposed decision and feel strongly that 18F NaF should be nationally covered by CMS because of its value in patient management.
Anderson, Jon Title: Dr.
Organization: Lake Medical Imaging
Date: 10/15/2015
Comment:
Lake Medical Imaging radiologists disagree with the proposed decision and feel strongly that 18F NaF should be nationally covered by CMS because of its value in patient management.
Hillner, Bruce Title: Chair
Organization: NOPR Working Group
Date: 10/14/2015
Comment:

On behalf of the National Oncologic PET Registry (NOPR) Working Group, we are pleased to provide these comments on the Proposed Decision Memorandum on Positron Emission Tomography (NaF-18) (CAG-00065R2).[1]

The NOPR Working Group appreciates and values its long and continued collaboration with the Centers for Medicare & Medicaid Services (CMS) in utilizing Coverage with Evidence Development (CED) to develop data-driven bases for the reasonable and necessary coverage of various

More

Curtis, Melanie Title: Supervisor Nuclear Medicine & PET/CT
Organization: Lake Medical Imaging & Breast Center
Date: 10/14/2015
Comment:

I, Melanie Curtis, C.N.M.T. from Lake Medical Imaging disagrees with the proposed decision and feel strongly that 18F NaF should be nationally covered by CMS because of its value in patient management.

Published in Journal of Nuclear Medicine, Shen et.al1 evaluated the diagnostic accuracy of 18 F NaF PET or PET/CT compared with traditional planar/SPET bone scintigraphy and glucose metabolic PET/CT in the detection of bone metastases. Using twenty published articles, the authors

More

Phelps, Patrick Title: President & CEO
Organization: SOFIE BIOSCIENCES
Date: 10/14/2015
Comment:
I understand your desire to see further evidence in publications on the value of NaF over Tc99m. But, I want you to consider another factor. Reactors around the world WILL start to fail, causing further supply interruptions on the starting material of Tc99m. Efforts to find alternative ways to supplement production on cyclotron or newer reactors will NOT occur in time. Not encouraging a move to NaF bone PET scans soon is a mistake. Don't put bone scans at risk.
PATEL, ROMIL Title: DR.
Organization: LAKE MEDICAL IMAGING
Date: 10/14/2015
Comment:

I disagree with the proposed decision and feel strongly that 18F NaF should be nationally covered by CMS because of its value in patient management.

Published in Journal of Nuclear Medicine, Shen et.al1 evaluated the diagnostic accuracy of 18 F NaF PET or PET/CT compared with traditional planar/SPET bone scintigraphy and glucose metabolic PET/CT in the detection of bone metastases. Using twenty published articles, the authors identified and reported data from 1170 patients in

More

Frangioni, John Title: Professor of Medicine and Professor of Radiology
Organization: Harvard Medical School
Date: 10/14/2015
Comment:
The NOPR CED Study was designed and statistically powered to answer the question requested by CMS, and it appears to have done just that. In fact, the data regarding change in management are overwhelming. Many of us in the field are confused by CMS' position and their request for more data to be collected. Patients will benefit both short- and long-term by the improved sensitivity and resolution of PET compared to SPECT and reimbursing NaF for bone scanning will accelerate this much-needed

More

Choyke, Peter Title: Senior Investigator
Organization: National Cancer Institute
Date: 10/14/2015
Comment:
NaF-18 scans are more sensitive than conventional bone scans. In patients with prostate cancer who are at high risk for metastases (high PSA, high Gleason Grade tumor), but who have a negative conventional bone scan, Na-F-18 scans are particularly useful in identifying metastases thus changing the management in this population. The decision to deny reimbursement for NaF-18 will result in unnecessary treatments and delay in appropriate treatments of the patients.
Hans, Brian Title: Territiry Manager
Organization: PETNET Solutions
Date: 10/14/2015
Comment:

Hello CMS,

I disagrees with the proposed decision and feel strongly that 18F NaF should be nationally covered by CMS because of its value in patient management.

Please see below literature as proof of its value.

Published in Journal of Nuclear Medicine, Shen et.al1 evaluated the diagnostic accuracy of 18 F NaF PET or PET/CT compared with traditional planar/SPET bone scintigraphy and glucose metabolic PET/CT in the detection of bone metastases. Using twenty

More

Frank, Richard Title: MD, PhD, Chief Medical Officer
Organization: Siemens Healthcare
Date: 10/13/2015
Comment:

October 12, 2015

CAGInquiries@cms.hhs.gov

Tamara Syrek Jensen, Esq.
Director, Coverage and Analysis Group
Centers for Medicare & Medicaid Services
Department of Health and Human Services
7500 Security Boulevard
Baltimore, MD 21244

Re:Comments on Proposed Decision Memorandum (CAG-00065R2)Positron Emission Tomography (NaF-18) to Identify Bone Metastasis of Cancer

Dear Director Syrek Jensen;

On behalf of

More

Goodwin, Mary Title: Mrs.
Date: 10/12/2015
Comment:

I’m writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to provide the highest diagnostic accuracy

More

Bridges, Robert Title: M.D.
Organization: Aegis Imaging Consultants
Date: 10/12/2015
Comment:

I wish to comment on the present status of determination by CMS on the decision against expanded utilization and reimbursement of NaF-18 for diagnosis of malignant bone disease. As a diagnostic imaging specialist, being boarded in both diagnostic radiology and nuclear medicine with over 30 years of clinical experience, and as both an early adopter of NaF-18 bone imaging and the pioneer of PET imaging in Alaska, I have taken a keen interest in the comments, evaluation and determination of

More

Amos, Donna Date: 10/03/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Garner, Lynda Date: 10/03/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Hardin, Cam Date: 10/03/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Mendola, Michael Date: 10/03/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Moore, Gary Title: Mr
Date: 10/02/2015
Comment:

To whom this may concern,

I’m writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Alyabari, Sandra Date: 10/02/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Berg, Deborah Date: 10/02/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Blackwood, Barbara Date: 10/02/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Braeback, Cathryn Date: 10/02/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Brown, Cynthia Date: 10/02/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Carpenter, Dorothy Date: 10/02/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Cieslinski, James Date: 10/02/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Clark, Kathy Date: 10/02/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Cooper, LeRoy Date: 10/02/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Diamond, Patti Date: 10/02/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Frank, Carole Date: 10/02/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Fromwiller, Judith Date: 10/02/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Granger, Deborah Date: 10/02/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Horsch, Thomas Date: 10/02/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Lipinski, Lisa Date: 10/02/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Lloyd, William Date: 10/02/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

MacKay-O'Brien, Caryn Date: 10/02/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

mazur, * Date: 10/02/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Micham, Terence Date: 10/02/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Nussbaum, Wilfred Date: 10/02/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

O'Brien, Robert Date: 10/02/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Pullen, Pamela Date: 10/02/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Richards, Sallie Date: 10/02/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Salerno, Barbara Date: 10/02/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

sulla, carol Date: 10/02/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

sulla, Gaitano Date: 10/02/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

sulla, Felice Date: 10/02/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Verdon, Lucia Date: 10/02/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Wauben, Phillip Date: 10/02/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Webber, Joan Date: 10/02/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Yoder, Lynnette Date: 10/02/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

*, huey Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

angrisani, cynthia Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Apsche, Joanne Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

B, dennis Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Bloyd, Genell Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Boggio, Frank Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Borelli, Candace Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Brown, Elizabeth Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Brzezinski, Debra Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Cicci, Diane Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

colon, Maria Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Deal, Floyd Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

DeVries, Sidney Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

downes, dorien Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Edwards, Ruth Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

fazio, sandra Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Fisher, Kenneth Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Haigh, Constance Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Hart, Michele Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Hill, Karen Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

J, Dane Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Kemp, Suzanne Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Kuntz, Stephen Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Lamer-Thomas, Laura Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

landers, Mary Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

madsen, Jeri Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

McCorriston, Catherine Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Morrow, Linda Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

murray, anita Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Nix, Jean Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Organ, Ann Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Philpot, Adrienne Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Renner, Vickie Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Richter, William Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Robison, Janet Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Rodriguez, Patricia Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Shafkind, Gale Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Steiner, David Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Steiner, Sharon Date: 10/01/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Dembny, Kathleen Organization: .
Date: 09/30/2015
Comment:

PET(NaF-18) was a key part of treatment fir [PHI Redacted] and for a dear friend. Denying this is playing Russian Roulette with the lives of those who HAVE PROVIDED THE MONEY the federal government now seeks to withhold!!

Lowentritt, Benjamin Title: Physician
Organization: Chesapeake Urology Associates
Date: 09/30/2015
Comment:

It is very disappointing that after several years of compiling information, CMS has decided not to cover Sodium Fluoride PET scanning. I treat men with advanced, metastatic prostate cancer, and the improved specificity and earlier diagnosis of bone metastases provided by NaF PET has allowed dozens of my patients access to treatment otherwise not allowable. The finding of metastatic disease is necessary for access to most treatments for these patients, and all these treatments are shown to

More

abner, Patricia Date: 09/30/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Ali, Doreen Date: 09/30/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Baker, Virginia Date: 09/30/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Brauneck, Ruth Date: 09/30/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

bridges, Caroline Date: 09/30/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Christensen, Vickie Date: 09/30/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Corsi, Lawrence Date: 09/30/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Duval, Robin Date: 09/30/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Grimaud, Diane Date: 09/30/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Haire, Carolyn Date: 09/30/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

L, Christine Date: 09/30/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Lindeman, Jan Date: 09/30/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Lix, Robert Date: 09/30/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown

More

MacKenzie, Gilbert Date: 09/30/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

maryanski, patricia Date: 09/30/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Moore, Gayle Date: 09/30/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

morden, Mark Date: 09/30/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Moretz, Sean Date: 09/30/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Olsen, Alfred Date: 09/30/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Resende, Stephen Date: 09/30/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Riffe, Regina Date: 09/30/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Robbins, Linda Date: 09/30/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Smogoleski, Suzanna Date: 09/30/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Tyndall, James D. Date: 09/30/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Woodcox, Jean Date: 09/30/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Wren, Jennifer Date: 09/30/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Dicks, Brian Title: Urologist
Date: 09/29/2015
Comment:

I encourage CMS to reconsider their position regarding coverage for NaF Pet scans. As a practicing urologist I have been very impressed with the ability to detect early bone metastasis in my prostate cancer patients who have had a negative bone scan. There have been many developments in the realm of castrate resistant prostate cancer and early detection of bone metastasis allows us to aggressively treat these mets with a number of novel agents. This clearly leads to better palliation of

More

Henry, Wendy Date: 09/29/2015
Comment:

To whom this may concern,

My [PHI Redacted] passed away from prostate cancer in [PHI Redacted], less than one month past his 67th birthday. He fought a gallant, pain-filled battle from his diagnosis just two years before until his cancer-wrenched body no longer could fight. In the end, there was nothing more the doctors could do. His oncologist cried when he told [PHI Redacted] the treatments were finished.

I will never

More

Belias, Elena Date: 09/29/2015
Comment:

To whom this may concern,

I’m writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

SMITH, MARY Organization: BORG & IDE IMAGING
Date: 09/29/2015
Comment:

To whom this may concern,

I’m writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Andre, Jill Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Austill, Norman Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Baker, Deborah Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Bilyeu, Sheryl Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Bohler, Judith Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Burnette, Linda Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

dondelinger, virginia Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Douglas, David Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Estades, Jorge Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Globke, Ellen Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Greenfield, Jody Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

H, Jolene Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

HaringDavner, Lisa Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Hildreth, Jean Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

hill, Colleen Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Holley, Doug Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Huddlestom, Leslie Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Hudson, James Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Larson, Muriel Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Marshall, Terri Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

mastriano, Denise Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

mcphail, Jack Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

MEROLA, DEBORAH Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Mules, Carole Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Ozor, Barbara Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

R, Steve Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Racette, Annette Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Roberts, Rosemary Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Ross, Dakita Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Ruggiero, Barbara Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Senanefes, Barbara Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Shillinglaw, Donald Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Smith, Phillip Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Spears, Vickie Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Stephenson, Linda Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Stockton, Marilyn Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Stoudt, Donald Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Stroup, Shari Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

T, Sue Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Timothy, Patricia Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Tresvik, Germaine Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Tyner, Julia Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

uhl, debra Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

wood, James Date: 09/29/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Bourgault, John Date: 09/28/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Butow, Vicky Date: 09/28/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Cannella, Rita Date: 09/28/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

dalton, colleen Date: 09/28/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Dingman, Vicki Date: 09/28/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Dunne, Lucille Date: 09/28/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Greve, David Date: 09/28/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Gueck, M. Date: 09/28/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Hickson, Nedra M. Date: 09/28/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

LAYTON, DALE Date: 09/28/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Little, Pam Date: 09/28/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

miller, terry Date: 09/28/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

morris, cheryl Date: 09/28/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Norris, Barbara Date: 09/28/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Rosas, Ruth Date: 09/28/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Seymour, Karen Date: 09/28/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Snyder, Mary Date: 09/28/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Ueberroth, Nancy Date: 09/28/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Vix, Janice Date: 09/28/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Ward, Teresa Date: 09/28/2015
Comment:

To whom this may concern,

I'm writing to urge the Centers for Medicare and Medicaid Services to reconsider its recent decision regarding coverage for the NaF-18 positron emission tomography (PET) scan to identify bone metastasis of cancer and instead finalize a decision to cover this important scan.

I know first-hand the critical role of advanced diagnostic tools in helping prostate cancer patients achieve a better quality of life. The NaF PET scan has been shown to

More

Middlebrooks, James Tyler Title: Nuclear Medicine Technologist
Organization: CARTI Diagnostic Imaging
Date: 09/25/2015
Comment:

I personally have seen numerous times where a patient's PSA was at a 1.5 and above and bone Mets were detected with a negative conventional bone scan. This allows patients to start chemo earlier and detect cancer before it spreads/grows large enough for a conventional bone scan to detect. Please reconsider the coverage of this exam. It is an extremely helpful tool in improving patent health and overall survival rates. Please reconsider and allow coverage through CMS.

your truly,

More

Cullari, Thomas Date: 09/17/2015
Comment:
I have found many patients to benifit from the technology offered in F-18 Bone scan in comparison to a planer bone scan. Many physicians have been unsucseful in finding bone mets with the old technology and thus had to order the exam several times to only find that the mets have spread exstensively. The early detection that is provided by NaF is monumental. The sensitivity and spcificity numbers alone would convince anyone who needed this type of exam to choose NaF over planer any day. We are

More

Pepe, Michele Title: Manager Radiology
Organization: Yale New Haven Hospital
Date: 09/17/2015
Comment:
I do not fully agree with the decision CMS has made about NaF18 bone imaging. We all decide to go into the medical field for patient care and providing a service to all patient to diagnose, treat and care.
We are doing an injust to men with prostate cancer by not providing NaF18 bone imaging, I have seen negative Tc99m bone scans and same patient repeated with NaF18 be postive, again we are all in this for patient care.
Messer, Guy Title: CEO
Organization: Trident Medical Imaging
Date: 09/16/2015
Comment:
While I appreciate the thoroughness of CMS' evaluation, I am concerned that CMS is instituting undue restrictions in the approval process. CMS itself initiated the national clinical trial process to evaluate new PET tracers and indications such as F-18 PET Bone Scans and when the data provided overwhelmingly supports its use, CMS adds another layer of restricted utilization in the form of a 12-month extension to answer the question that appears to have already been answered by the trial

More